enow.com Web Search

  1. Ads

    related to: myasthenia foundation drugs to avoid risk

Search results

  1. Results from the WOW.Com Content Network
  2. Rozanolixizumab - Wikipedia

    en.wikipedia.org/wiki/Rozanolixizumab

    Rozanolixizumab, sold under the brand name Rystiggo, is a monoclonal antibody used for the treatment of myasthenia gravis. [1] Rozanolixizumab is a humanized and chimeric monoclonal antibody; [4] and is a neonatal Fc receptor blocker.

  3. Myasthenia gravis - Wikipedia

    en.wikipedia.org/wiki/Myasthenia_gravis

    Myasthenia gravis affects 50 to 200 people per million. [3] [4] It is newly diagnosed in 3 to 30 people per million each year. [13] Diagnosis has become more common due to increased awareness. [13] Myasthenia gravis most commonly occurs in women under the age of 40 and in men over the age of 60. [1] [5] [14] It is uncommon in children. [1]

  4. Efgartigimod alfa - Wikipedia

    en.wikipedia.org/wiki/Efgartigimod_alfa

    Efgartigimod alfa as a drug is an antibody fragment that binds to the neonatal Fc receptor. When this binding happens, the IgG recycling process is blocked. The amount of circulating IgG decreases and therefore prevents the acetylcholine receptors from being degraded by the autoantibodies that are responsible for the myasthenia gravis. [14]

  5. Transient neonatal myasthenia gravis - Wikipedia

    en.wikipedia.org/wiki/Transient_neonatal...

    Transient neonatal myasthenia gravis; Specialty: Pediatrics, Pediatric neurology, Pediatric pulmonology, Pediatric intensive care medicine: Symptoms: skeletal muscles weaknesses and, in rare cases. organ deformities in one or more areas of the body in fetuses and newborns

  6. Neostigmine - Wikipedia

    en.wikipedia.org/wiki/Neostigmine

    Neostigmine, sold under the brand name Bloxiverz, among others, is a medication used to treat myasthenia gravis, Ogilvie syndrome, and urinary retention without the presence of a blockage. [ 3 ] [ 4 ] It is also used in anaesthesia to end the effects of non-depolarising neuromuscular blocking medication . [ 3 ]

  7. Pyridostigmine - Wikipedia

    en.wikipedia.org/wiki/Pyridostigmine

    Pyridostigmine is a medication used to treat myasthenia gravis [1] and underactive bladder. [2] It is also used together with atropine to end the effects of neuromuscular blocking medication of the non-depolarizing type. [3] It is also used off-label to treat some forms of Postural orthostatic tachycardia syndrome.

  8. Performance Enhancing Drugs: What's Safe, and What to Avoid - AOL

    www.aol.com/lifestyle/performance-enhancing...

    Performing enhancing drugs, PEDs, are popular on social media. Our experts break down the effects of testosterone, HGH, tren, Clenbuterol, TRT, and more. Performance Enhancing Drugs: What's Safe ...

  9. Edrophonium - Wikipedia

    en.wikipedia.org/wiki/Edrophonium

    In myasthenia gravis, the body produces autoantibodies which block, inhibit or destroy nicotinic acetylcholine receptors in the neuromuscular junction. Edrophonium—an effective acetylcholinesterase inhibitor —will reduce the muscle weakness by blocking the enzymatic effect of acetylcholinesterase enzymes, prolonging the presence of ...

  1. Ads

    related to: myasthenia foundation drugs to avoid risk